Registration form
Remind me later

14th European Regional Conference on Thoracic Oncology: Is more always better?

Date, time
Thu, Jun 15 2023, 15:00 - Fri, Jun 16 2023, 19:00
Location
Radisson Blu Hotel Lietuva, Vilnius
1
14th European Regional Conference on Thoracic Oncology: Is more always better?
CREATIVA
Price
Vardas ir pavardė sertifikate bus įrašyti taip, kaip nurodysite formoje

Dear Colleagues,

We are proud to invite you to participate in the “14th European Regional Conference on Thoracic Oncology: Is more always better?, which will be held on 15-16th of June, 2023 in hotel “Radisson Blu hotel Lietuva” (Konstitucijos ave. 20), Vilnius, Lithuania.

The conference is intended for oncologists, medical oncologists, clinical oncologists, radiation oncologists, radiologists, thoracic surgeons, general surgeons, pulmonologists, family doctors, internists, pathologists, medical biologists, other medical specialists.
Planned number of conference participants 200.

PARTICIPATIONS
On June 15 participants have the opportunity to participate directly in a live conference at the “Radisson Blu hotel Lietuva”.
On June 16 participants have the opportunity to participate directly in a live conference at the “Radisson Blu hotel Lietuva” or watch the conference remotely.

You can find a programme and a short biography of the speakers here: 14 Thoracic Oncology Speakers CV

The day before the event, all participants who register for the remote conference will receive a personal login link with their access codes. During the conference, you will be able to follow the messages on your device and ask written questions to the speakers, who will be answered during the discussion.

REGISTRATION
Conference is free of charge, but registration is mandatory.

CERTIFICATES
Certificates will be sent to participants who have attended the conference.

 

PROGRAMME DOWNLOAD
Conference secretariat | CREATIVA +37067598094 ivona@creativa.lt
Price
Conference is free of charge
PROGRAMME (Vilnius, Lithuania ‎(UTC+3)‎)
15 June
14:00 - 15:00
Registration
15:10 - 15:55
Epidemiology/ Tobaco Control/ Lung Cancer Screening Chairs: Giedre Smailyte (Vilnius, Lithuania), Vaida Gedvilaite (Vilnius Lithuania)
15:10 - 15:25
Epidemiology of lung cancer Giedre Smailyte (Vilnius, Lithuania) onsite
15:25 - 15:40
Lung Cancer and Genomics Marcin Moniuszko (Bialystok, Poland) online
15:40 - 15:55
Lung Cancer Screening: means to overcome current challenges Wieland Voigt (Erlangen, Germany) onsite
16:00 - 16:40
Young investigators session Chairs: Kestutis Suziedelis (Vilnius, Lithuania) Saulius Cicenas (Vilnius Lithuania)
16:00 - 16:15
Biobanks: the essential resource for lung cancer early detection and targeted therapy Anna Michalska Falkowska (Bialystok, Poland) onsite
16:15 - 16:30
The role of microRNAs in Cancer treatment -induced Cardiotoxicity Paulina Kazlauskaite (Vilnius, Lithuania) onsite
16:30 - 16:40
Discussion
16 June
7:00 - 8:00
Registration
8:00 - 8:30
Welcome address Moderators: Christian Manegold (Mannheim, Germany), Jacek Niklinski (Bialystok, Poland), Saulius Cicenas (Vilnius, Lithuania)
Zivile Gudleviciene - Advicer to the Prime Minister on Healthcare and People with Disabilities
Dalius Jatuzis - Dean of the Faculty of Medicine Vilnius University
Neringa Ciakiene - Director of Lithuanian Cancer Patients Coalition „POLA“
Marius Kincius - Deputy Director of National Cancer Institute
08:35 - 9:30
Lung Cancer Diagnostics Chairs: Kestutis Suziedelis (Vilnius, Lithuania), Jacek Niklinski (Bialystok, Poland)
08:35 - 08:50
Current diagnostic criteria for mesothelioma diagnosis Mauro Papotti (Torino, Italy) online
08:50 - 09:05
Pseudoprogression and Hyperprogression During Immune Checkpoint Inhibitor Therapy for Solid Tumors Rossitza Krasteva (Sofia, Bulgaria) onsite
09:05 - 9:20
Advances in Lung Cancer Imagining Donatas Vajauskas (Kaunas, Lithuania) onsite
9:20 - 9:30
Discussion
9:35-9:50
Coffee break
9:55-10:40
Surgery for Lung Cancer Chairs: Saulius Cicenas (Vilnius, Lithuania), Miroslaw Kozlowski (Bialystok, Poland)
9:55-10:10
Treatment of lung metastases in thoracic oncology Miroslaw Kozlowski (Bialystok, Poland) onsite
10:10-10:25
Surgical treatment of multiple primary lung cancer: every lesions matter Sigitas Zaremba (Vilnius, Lithuania) onsite
10:25-10:40
Discussion
10:45-11:20
Satellite Roche Chairs: Kestutis Suziedelis (Vilnius, Lithuania)
10:45-11:20
Immune therapy for 1L treatment in advanced NSCLC Alvydas Cesas (Klaipeda, Lithuania) onsite
11:25-11:40
Coffee break
11:45-12:20
Satellite BMS Chairs: Alvydas Cesas (Klaipeda, Lietuva)
11:45-12:20
Added value of dual immunotherapy and chemotherapy in first line treatment of NSCLC Lina Puzauskiene (Kaunas, Lithuania) onsite
12:25-13:25
Satellite MSD Chairs: Saulius Cicenas (Vilnius, Lietuva)
12:25-13:25
Treatment decisions for first line metastatic NSCLC: Balancing monotherapy vs combination Marius Zemaitis (Kaunas, Lithuania) onsite
13:30-14:35
Lunch
14:35-15:30
Multimodality Lung cancer Treatment
Session 1 Chairs: Rita Steponaviciene (Vilnius, Lithuania), Mikk Saretok (Talinn, Estonia)
14:35-14:50
NSCLC: newer aspects on preoperative medical therapy. Christian Manegold (Manheim, Germany) onsite
14:50-15:05
Immune checkpoint inhibitors as adjuvant therapy in patients with resected NSCLC Robert Pirker (Vienna Austria) online
15:05-15:20
Radical Radiotherapy in NSCLC in Baltic States/Estonia Mikk Saretok (Talinn, Estonia) onsite
15:20-15:30
Discussion
15:30-16:05
Satellite Pfizer

15:30-16:05
Modern treatment modalities of ALK mutated non-small cell lung cancer Neringa Vaguliene (Kaunas, Lithuania) onsite
16:05-16:20
Coffee break
16:25-17:25
Satellite AstraZeneca
16:25-17:25
Treatment of extensive stage small cell lung cancer. What is the role of durvalumab? Bjorn Henning Gronberg (Trondheim, Norway) onsite
17:30 - 18:25
Multimodality Lung cancer Treatment
Session 2
Chairs: Rita Steponaviciene (Vilnius, Lithuania), Mikk Saretok (Talinn, Estonia)
17:30-17:45
Modern Management of SCLC Sofia Baka (Athens, Greece) online
17:45-18:00
Current clinical study concepts in lung cancer Lothar Richard Pilz (Manheim, Germany) onsite
18:00-18:15
The combination of radiotherapy andhemotherapy in the management of SCLC Treatment in China Yi Pan (Guanghzou, China)
18:15 - 18:25
Discussion
18:30 - 18:45
Closing Remarks Moderation: Saulius Cicenas (Vilnius, Lithuania), Jacek Niklinski (Bialystok, Poland), Christian Manegold (Manheim, Germany)
19:00
Dinner